Insiders Buying BranchOut Food And 2 Other Stocks

Although US stocks closed higher for the fourth session in a row, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

BranchOut Food

  • The Trade: BranchOut Food Inc. BOF Director John Dalfonsi acquired a total of 30,000 shares an average price of $5.81. To acquire these shares, it cost around $174,400.
  • What’s Happening: BranchOut Food recently announced product development program with U.S. Army to revolutionize MREs with GentleDry technology.
  • What BranchOut Food Does: Branchout Food inc is an international food-tech company delivering truly extraordinary natural snacks and real superfood ingredients enabled by Its new, licensed dehydration technology.

Nuvectis Pharma

  • The Trade: Nuvectis Pharma, Inc. NVCT 10% owner Charles Mosseri-Marlio acquired a total of 3,285 shares at an average price of $15.09. To acquire these shares, it cost around $49,571.
  • What’s Happening: Nuvectis Pharma recently announced FDA clearance of NXP900 IND.
  • What Nuvectis Pharma Does: Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology.

Don’t forget to check out our premarket coverage here

BBX Capital

  • The Trade: BBX Capital, Inc. BBXIA CEO and President Jarett Levan bought a total of 141,577 shares at an average price of $11.20. To acquire these shares, it cost around $1.36 million.
  • What’s Happening: The company posted first-quarter diluted earnings per share of $0.55, compared to year-ago diluted loss per share of $0.12.
  • What BBX Capital Does: BBX Capital Inc is a diversified holding company. Its principal investments include BBX Capital Real Estate, Renin, and BBX Sweet Holdings.

 

Check This Out: Citigroup Likely To Report Lower Q2 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!